4,5-Dibromo-6-(trifluoromethyl)pyrimidine, 95.0%, 1g

4h,6h,7h-Pyrano[4,3-d][1,3]thiazole-2-carbaldehyde, 95%, 100mg

5-Amino-N,N'-bis(2,3-dihydroxypropyl)isophthalamide Hydrochloride>98.0%(HPLC)(N)5g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(2-((tert-butoxycarbonyl)amino)ethoxy)phenyl)propanoic acid, 97%, 100g

Nonafluorobutyl Iodide>98.0%(GC)25g

1-(3-Cyanophenyl)piperazine, 97.0%, 5g

2,6-Diisopropylpyridine, 97%, 100mg

(3R,5R)-5-(Hydroxymethyl)pyrrolidin-3-ol hydrochloride, 97.0%, 1g

6-Methyl-4-(trifluoromethyl)pyridin-2-amine, 97.0%, 100mg

4-Fluoro-3-methylaniline, 98.0%, 100g

2,4'-Bipyridine, 97.0%, 10g

4-Methyl-n-octanoic Acid>98.0%(T)5g

GC capillary column ROTI®Cap-1, 25 m, 0.20 mm, 0.35 µm, 1 Piece(s)